Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Clinical trial NCT05259696 · COMPLETED

Trial details

NCT number: NCT05259696
Sponsor: Palleon Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Oncology Melanoma Ovarian Cancer NSCLC Non Small Cell Lung Cancer Colorectal Cancer Pancreatic Cancer Cancer CRC Colon Cancer Breast Cancer Gastric Cancer

Start date: 2022-02-11
Primary completion: 2024-10-24
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.